Drugs for Soft Palate Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Motexafin gadolinium |
Investigational |
Phase 1 |
|
246252-06-2, 156436-89-4 |
12047567 |
|
Synonyms:
156436-89-4
D05080
gadolinium diacetate (1Z,7Z,12E,20E)-4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-10,23-dimethyl-13,20,25,26,27-pentaazapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1,3,5,7,9,11(26),12,14,16,18,20,22(25),23-tridecaen-27-ide
Gadolinium texaphyrin
GdT2B2
GD-Tex
|
Motexafin gadolinium
Motexafin gadolinium (USAN)
PCI-0120
Xcytrin
Xcytrin (TN)
|
|
| 2 |
|
Photosensitizing Agents |
|
Phase 1 |
|
|
|
| 3 |
|
Dermatologic Agents |
|
Phase 1 |
|
|
|
Interventional clinical trials:
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
A Randomized Trial Comparing Preservation of Function Status After Either Medpulser Electroporation With Intratumoral Bleomycin Therapy or Surgery in Patients With Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Anterior Oral Cavity, Soft Palate, or Tonsil That Have Failed Primary Curative Therapy |
Withdrawn |
NCT00198315 |
Phase 3 |
|
| 2 |
Phase I Trial of Motexafin Gadolinium and Chemoradiation in Locally Advanced, Squamous Cell Carcinoma of the Head and Neck |
Terminated |
NCT00080028 |
Phase 1 |
Motexafin Gadolinium Injection |
|
